Comprehensive genetic counseling for families at risk for HNPCC: Impact on distress and perceptions

Genetic Testing

Volumn 6, Issue 4, 2002, Pages 291-302

  Keller, Monika ^a   Jost, R ^a   Haunstetter, C Mastromarino ^a   Kienle, P ^a   Knaebel, H P ^a   Gebert, J ^a   Sutter, C ^a   Knebel Doeberitz, M V ^a   Cremer, F ^a   Mazitschek, U ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE; COLORECTAL CANCER; COPING BEHAVIOR; DISTRESS SYNDROME; EARLY DIAGNOSIS; FAMILY; FEAR; FEMALE; GENETIC COUNSELING; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SELF CONTROL; SYMPTOMATOLOGY;

ADULT; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED;

EID: 12244250746     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/10906570260471822     Document Type: Article

References (54)

1. Aktan-Collan, K., Mecklin, J.-P., Jarvinen, H., Nystrom-Lahti, M., Peltomaki, P., and Soderling, I. (2000). Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Int. J. Cancer, 89, 44-50.
2. Baum, A., Friedman, A.L., and Zakowski, S.G. (1997). Stress and genetic testing for disease risk. Health Psychol. 16, 8-19.
3. Bleiker, E.M.A., Aaronson, N.K., Menko, F.H., Hahn, D.E.E., Van Asperen, C.J., Rutgers, E.J.T., Ten Kate, L.P., and Leschot, N.J. (1997). Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members. Patient Educ. Counsel. 32, 107-116.
4. Brahler, E., and Scheer, J. (1983). Der Gießener Beschwerdebogen (GBB). Handbuch. (Bern, Huber).
5. Bullinger, M., Kirchberger, I., and Ware, J. (1995). Der Deutsche SF-36 Health Survey. Übersetzung und Psychometrische Testung Eines Krankheits-übergreifenden Instrumentes zur Erfassung der Gesundheitsbezogenen Lebensqualität. Z. f. Gesundheitswissenschaften 1, 21-36.
6. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M.J.E., Lynch, P., McTiernan, A., and Offit, K. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. J. Am. Med. Assn. 277, 997-1003.
7. Codori, A.M., Hansen, R., and Brandt, J. (1994). Self-selection in predictive testing for Huntington's disease, Am. J. Med. Genet, 54, 167-173.
8. Codori, A.-M., Petersen, G.M., Miglioretti, D.L., Larkin, E.K., Bushey, M.T., Young, C., and Brensinger, J.D. (1999). Attitudes toward colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiol. Biomarkers Prev. 8, 345-351.
9. Croyle, R.T. (1995). Psychosocial Effects of Screening for Disease Prevention and Detection. (Oxford University Press, New York Oxford).
10. Cull, A., Anderson, E., Campbell, S., Mackay, J., Smyth, E., and Steel, M. (1999). The impact of genetic counseling about breast cancer risk on women's risk perception and levels of distress. Br. J. Cancer 79, 501-508.
11. De Vos, M., Poppe, B., Delvaux, I., Mortier, G., Claes, K., Messiaen, L., et al. (1999). Genetic counseling and testing for hereditary breast and ovarian cancer: The Gent(le) approach. Dis. Markers 15, 191-195.
12. Dorval, M., Farkas, P., Schneider, K., et al. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. J. Clin. Oncol. 18, 2135-2142.
13. Dudokdewit, A.C., Tibben, A., Frets, P.G., Meijersheijboer, E.J., Devilee, P., Klijn, J.G.M., Osterwijk, J.C., and Niermeijer, M.F. (1997). BRCA1 in the family: a case description of the psychological implications. Am. J. Med. Genet. 71, 63-71.
14. Dudokdewit, A.C., Tibben, A., Duivenvoorden, H.J., Niermeijer, M.F., and Passchier, J. (1998a). Predicting adaptation to presymptomatic DNA testing for late onset disorders: Who will experience distress? J. Med. Genet. 35, 745-754.
15. Dudokdewit, A.C., Tibben, A., Duivenvoorden, H.J., Niermeijer, M.F., Passchier, J., and Trijsburg, R.W. (1998b). Distress in individuals facing predictive DNA testing for autosomal dominant inheritable late onset disorders; comparing questionnaire results with in-depth interviews. Am. J. Med. Genet. 75, 62-74.
16. Evans, D., Blair, V., Greenhalgh, R., Hopwood, P., and Howell, A. (1994). The impact of genetic counseling on risk perception in women with a family history of breast cancer. Br. J. Cancer 70, 934-938.
17. Green, M., McInerney, A., Biesecker, B., and Fost, N. (2001). Education about genetic testing for breast cancer susceptibility: Patient preferences for a computer program or genetic counselor. Am. J. Med. Genet. 103, 24-31.
18. Herrmann, C. (1997). International experiences with the hospital anxiety and depression scale - A review of validation data and clinical results. J. Psychosom. Res. 42, 17-41.
19. Hinz, A., and Schwarz, R. (2001). Angst und depression in der allgemeinbevölkerung. Psychother. Psychosom. Med. Psychol. 51, 193-200.
20. Hopwood, P. (1997). Psychological issues in cancer genetics: Current research and future priorities. Patient Educ. Counsel. 32, 19-31.
21. Hopwood, P. (1998). Genetic risk counseling for breast cancer families. Eur. J. Cancer 34, 1477-1479.
22. Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., and Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: Some preliminary indicators. Psychooncology 7, 402-412.
23. Horowitz, M., Wilner, N., and Alvarez, W. (1979). Impact of events scale: A measure of subjective stress. Psychosomat. Med. 41, 209-218.
24. Jacobsen, P.B., Valdimarsdottir, H.B., Brown, K.L., and Offit, K. (1997). Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomat. Med. 59, 459-466.
25. Julian-Reynier, C., Eisinger, F., Vennin, P., Chabal, F., Aurran, Y., Nogues, C., et al. (1996). Attitudes towards cancer predictive testing and transmission of information to the family. J. Med. Genet. 33, 731-736.
26. Kash, K.M., Holland, J.C., Halper, M.S., and Miller, D.G. (1992). Psychological distress and surveillance behaviors of women with a family history of breast cancer. J. Natl. Cancer Inst. 84, 24-30.
27. Kinzler, K.W., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
28. Lerman, C., Trock, B., Rimer, B.K., Boyce, A., Jepson, C., and Engstrom, P.F. (1991). Psychological and behavioral implications of abnormal mammograms. Ann. Int. Med. 114, 657-661.
29. Lerman, C., Daly, M., Sands, C., Balshem, A., Lustbader, E., Heggan, T., Goldstein, L., James, J., and Engstrom, P. (1993). Mammography adherence and psychological distress among women at risk for breast cancer. J. Natl. Cancer Inst. 85, 1074-1080.
30. Lerman, C., Daly, M., Masny, A., and Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol. 12, 843-850.
31. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., and Trock, B. (1996a). BRCA1 testing in families with hereditary breast-ovarian cancer - A prospective study of patient decision making and outcomes. J. Am. Med. Assn. 275, 1885-1892.
32. Lerman, C., Marshall, J., Audrain, J., and Gomez-Caminero. (1996b). Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int. J. Cancer 69, 58-61.
33. Lerman, C., Schwartz, M.D., Rimer, B.K., Miller, S.M., Daly, M., and Sands, C. (1996c). A randomized trial of breast cancer risk counseling: Interacting effects of counseling, educational level, and coping style. Health Psychol. 15, 75-83.
34. Lerman, C., Biesecker, B., Benkendorf, J.L., Kerner, J., Gomez-Caminero, A., Hughes, C., and Reed, M.M. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J. Natl. Cancer Inst. 89, 148-157.
35. Lerman, C., Highers, C., Lemon, S.J., Main, D., Snyder, C., Durham, C., Narod, S., and Lynch, H.T. (1998). What you don't know can hurt you: Adverse psychologic effects in members of BRCA2-linked families who decline genetic testing. J. Clin. Oncol. 16, 1650-1654.
36. Lloyd, S., Watson, M., Waites, B., Meyer, L., Eeles, R., Ebbs, S., and Tylee, A. (1996). Familial breast cancer: A controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counseling. Br. J. Cancer 74, 482-487.
37. Lodder, L., Frets, P., Trijsburg, R., Meijers-Heijboer, E., Klijn, J., Duivenvoorden, H., Tibben, A., Wagner, A., et al. (1999). Presymptomatic testing for BRCA1 and BRCA2: How distressing are the pre-test weeks? J. Med. Genet. 36, 906-913.
38. Lodder, L., Frets, P., Trijsburg, R., Meijers-Heijboer, E., Klijn, J., Duivenvoorden, H., Tibben, A., Wagner, A., Van Der Meer, C., Van Den Ouweland, A., and Niermeijer, M. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. Am. J. Med. Genet. 98, 15-24.
39. Lyman, G.H., and Kuderer, N.M. (1997). Basic population and cancer genetics and their use in the assessment of cancer risk. Eur. J. Cancer 33, 2160-2166.
40. Lynch, H.T., Smyrk, T., and Lynch, F.J. (1998). Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch Syndrome). Oncology 55, 103-108.
41. Mangold, E., Friedl, W., and Propping, P. (2000). Erbliches kolorektales karzinom - Was kann die molekulargenetische diagnostik leisten? Onkologe 6, 465-472.
42. Marteau, T.M., Dundas, R., and Axworthy, D. (1997). Long-term cognitive and emotional impact of genetic testing for cystic fibrosis: The effects of test result and gender. Health Psychol. 16, 51-62.
43. McHorney, C., Ware, J.J., and Raczek, A. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31, 247-263.
44. Reichelt, J.G., Dahl, A.A., Heimdal, K., and Moller, P. (1999). Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations. Dis. Markers 15, 139-143.
45. Ritvo, P., Robinson, G., Irvine, J., Brown, L., Murphy, J., Stewart, D., et al. (1999). A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer. Gynecolog. Oncol. 74, 331-337.
46. Spielberger, C.D. (1983). Manual for the State-Trait Anxiety Inventory. (Consulting Psychologists Press, Palo Alto, CA).
47. Syngal, S. (2000). Hereditary nonpolyposis colorectal cancer: A call for attention. J. Clin. Oncol. 18, 2189-2190.
48. Thewes, B., Meiser, B., and Hickie, J. (2001). Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 10, 459-468.
49. Vasen, H.F.A., and Wijnen, J. (1999). Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer. Cytogenet. Cell Genet. 86, 136-139.
50. Vernon, S.W., Gritz, E.R., Peterson, S.K., Perz, C.A., Marani, S., Amos, C.I., and Baile, W.F. (1999). Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol. Biomarkers Prev. 8, 353-360.
51. Watson, M., Lloyd, S., Meyer, L., Eeles, R., Ebbs, S., and Murday, V. (1999). The impact of genetic counseling on risk perception and mental health in women with a family history of breast cancer. Br. J. Cancer 79, 868-874.
52. Welkenhuysen, M., Evers-Kieboom, G., Decruyenaere, M., Claes, E., and Denayer, L. (2001). A community based study on intentions regarding predictive testing for hereditary breast cancer. J. Med. Genet. 38, 540-547.
53. Wijnen, J., Vasen, H.F.A., Khan, P.M., Zwinderman, A.H., Van Der Klift, H., Mulder, A., et al. (1998). Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N. Engl. J. Med. 339, 511-518.
54. Zigmond, A., and Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361-370.